TEVA(TEVA) - 2023 Q1 - Earnings Call Transcript

Ran Meir - SVP, Investor Relations Richard Francis - President & CEO Eli Kalif - CFO Eric Hughes - Chief Medical Officer, Head of Research and Development Sven Dethlefs - Head, North America Commercial Operator Ran Meir Richard Francis We have an emerging innovative business, primarily driven by AUSTEDO and AJOVY, but recently about to be supported by UZEDY, our long-acting schizophrenia product, and this is gonna fuel continued growth going Now coming to our core business, our core generics business. This ...